//

Home Industry Bio Tech Bharat Biotech partners with B...

Bharat Biotech partners with Bilthoven Biologicals on oral polio vaccines


Bio Tech

Bharat Biotech Bilthoven Biologicals oral polio vaccines

Bharat Biotech announced a partnership with Bilthoven Biologicals B.V. to improve the production and supply of oral polio vaccines.

According to a statement from the business, Bharat Biotech has inked a deal whereby it will purchase pharmaceutical ingredients to manufacture oral polio vaccines (OPVs), which will be distributed both domestically in India and internationally.

Through this partnership, Bharat Biotech and Bilthoven Biologicals (BBio) will work together to secure the licenses and regulatory approvals needed to produce OPVs for sale in India for distribution throughout the world using medication materials made in the Netherlands at BBio.

In addition to guaranteeing a steady supply of oral polio vaccines and strengthening the country's effort to eradicate the disease, Bharat Biotech Executive Chairman Krishna Ella said that this partnership was an excellent example of collaboration between vaccine companies.

CEO of the Serum Institute of India, Adar Poonawalla, stated that the organization's goal is to completely eradicate polio globally, which is an important first step in lessening the disease's devastating effects on vulnerable groups.

According to the statement, as the global polio eradication drive moves closer to its crucial phase, our collaboration will boost efforts to establish a world free of the disease.

According to Ella, oral polio vaccines have been a crucial component of India's Universal Immunization Program (UIP) for a number of years, and Bharat Biotech is one of the major suppliers to immunization programs worldwide.


Business News


Recommended News

Latest Magazine